Abstract
The WHO currently recommends a 6-month course of isoniazid preventative therapy for HIV-infected individuals who have a positive tuberculin skin test or are living in areas where skin testing is not feasible and the prevalence of latent tuberculosis (TB) exceeds 30%. However, recent studies conducted in Africa have suggested that prophylaxis for longer than 6 months may be needed in TB-endemic regions. To examine this possibility, researchers conducted a double-blind trial among HIV-infected …
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
